Biotechnology Assets S.A. (BST) — Cash Flow Reinvestment Rate
Biotechnology Assets S.A. (BST) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting €1.99K (capex €1.99K ) from operating cash flow of €658.13K. Check earnings quality score of Biotechnology Assets S.A. to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Biotechnology Assets S.A. Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Biotechnology Assets S.A. across 5 annual periods. Explore Biotechnology Assets S.A. (BST) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Biotechnology Assets S.A. (2015–2023)
Year-by-year capital reinvestment analysis for Biotechnology Assets S.A.. For live market cap and broader valuation context, see BST market cap overview.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 6.83x | €325.97K | €47.74K | €325.97K | ▲ +15235.3% |
| 2020 | 0.04x | €391.53K | €8.79 Million | €391.53K | ▼ -99.4% |
| 2017 | 7.33x | €1.56 Million | €213.49K | €1.56 Million | ▲ +508.5% |
| 2016 | 1.20x | €3.27 Million | €2.71 Million | €3.27 Million | ▼ -82.2% |
| 2015 | 6.75x | €1.07 Million | €158.16K | €1.07 Million | — |